What does HER2 status mean for Lymphoma treatment

Q: What does HER2 status mean for Lymphoma treatment

Great question! Let me clarify an important distinction: HER2 status is not typically relevant for most lymphomas, which is why you won't see it discussed in standard lymphoma guidelines. Let me explain why and when it might come up. HER2 human epidermal growth factor receptor 2 is a protein that's primarily important in breast cancer and some gastric cancers. According to NCCN Guidelines for lymphomas—including Marginal Zone Lymphomas, Follicular Lymphoma, and Diffuse Large B-Cell Lymphomas—the

LymphomaMay 15, 2026Navis AI

Ask Navis about your situation

This answer is general. Get one about your specific case — no signup, answered right here.

or Upload your records for answers about your actual case

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

HER2 Status and Lymphoma Treatment

Great question! Let me clarify an important distinction: HER2 status is not typically relevant for most lymphomas, which is why you won't see it discussed in standard lymphoma guidelines. Let me explain why and when it might come up.

Why HER2 Isn't Standard for Lymphoma

HER2 (human epidermal growth factor receptor 2) is a protein that's primarily important in breast cancer and some gastric cancers. According to NCCN Guidelines for lymphomas—including Marginal Zone Lymphomas, Follicular Lymphoma, and Diffuse Large B-Cell Lymphomas—the focus is on different biomarkers that are specific to how lymphoma cells behave.

For lymphomas, doctors typically look for:

CD20 status (a protein on B-cell lymphomas that's targeted by immunotherapy)
CD10, BCL2, BCL6 (markers that help classify the lymphoma subtype)
Mutations in specific genes like TP53, MYC, or BCL2 rearrangements
ALK status (in certain large B-cell lymphomas)

The One Exception: Primary Mediastinal Lymphoma

There's a rare situation where HER2 might be relevant: in primary mediastinal large B-cell lymphoma (a lymphoma that develops in the chest). Some research has explored HER2 expression in this subtype, but it's not a standard treatment decision point in current NCCN Guidelines.

What You Should Do

If your pathology report mentions HER2:

Ask your oncologist specifically: "Is HER2 status relevant to my lymphoma subtype and treatment plan?"
Request clarification on which biomarkers are important for your specific diagnosis
Ask: "What mutations or markers will guide my treatment decisions?"

Questions to ask your care team:

What is my specific lymphoma subtype/diagnosis?
Which biomarkers were tested on my biopsy?
How do these biomarkers affect my treatment options?
Are there any targeted therapies available based on my specific markers?

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Ask Navis about your case

That answer is general. Ask about your specific situation — no signup, answered right here.

or Upload your records for answers about your actual case

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →